Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
145
datasets available to search
ShareScore release 0.9.0
Dataset results
145 results for “T-cell receptor”
Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies
ClinicalTrials.gov study NCT06462248. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
ClinicalTrials.gov study NCT05773040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL
ClinicalTrials.gov study NCT05554575. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic M
ClinicalTrials.gov study NCT06191887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
ClinicalTrials.gov study NCT06559189. IPD Sharing: NO. Countries: 1. Publications: 0.
CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies
ClinicalTrials.gov study NCT06316856. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy
ClinicalTrials.gov study NCT07075523. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05336383. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)
ClinicalTrials.gov study NCT04520711. IPD Sharing: NO. Countries: 1. Publications: 0.
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
ClinicalTrials.gov study NCT06652633. IPD Sharing: NO. Countries: 3. Publications: 0.
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pem
ClinicalTrials.gov study NCT04536922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases
ClinicalTrials.gov study NCT07392528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT06364423. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT05489991. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
ClinicalTrials.gov study NCT07297667. IPD Sharing: YES. Countries: 0. Publications: 0.
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
ClinicalTrials.gov study NCT05044039. IPD Sharing: NO. Countries: 1. Publications: 0.
Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy
ClinicalTrials.gov study NCT06552572. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies
ClinicalTrials.gov study NCT04011293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B
ClinicalTrials.gov study NCT07259070. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma
ClinicalTrials.gov study NCT04712864. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.